本平台为互联网非涉密平台,严禁处理、传输国家秘密、工作秘密或敏感信息

赶黄草总黄酮的安全性评价
CSTR:
作者:
作者单位:

作者简介:

蒋屿(2000-),女,在读硕士研究生,研究方向:中药化学与中药药理,E-mail:2295011717@qq.com 通讯作者:付满玲(1995-),女,硕士,助理实验师,研究方向:中药化学与中药药理,E-mail:1280337937@qq.com

通讯作者:

中图分类号:

基金项目:

四川省重点研发计划项目(2022YFS0436);四川省自然科学基金项目(2022NSFSC1738);泸州市科技计划项目(2023SYF120;2021-JYJ-109);四川省中医药管理局中医药科研专项课题(2020CP0029);西南医科大学-泸州市中医医院基地项目(2019-LH003);西南医科大学产学研合作培育项目(2022CXY01);西南医科大学大学生国家级创新创业训练计划项目(202310632074);西南医科大学校级项目(2021KQN023);精细化工应用技术泸州市重点实验室开放课题(HYJY-2106-B)


Safety Evaluation of Total Flavonoids from Penthorum chinense Pursh
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    评价赶黄草总黄酮(Total Flavonoids of Penthorum chinense Pursh, TFPCP)的安全性。参照GB 15193-2014《食品安全毒理学评价程序》及《保健食品及其原料安全性毒理学检验与评价技术指导原则(2020年版)》,对赶黄草总黄酮进行急性经口毒性试验、三项遗传毒性试验及大鼠28 d喂养试验的安全性评价。急性经口毒性试验中,赶黄草总黄酮对小鼠的半数致死量(Median Lethal Dose, LD50)大于10 g/(kg•BW),属无毒级;细菌回复突变(Bacterial Reverse Mutation, Ames)试验各剂量组结果呈阴性,且菌落数未超过TA97A、TA98、TA100溶剂对照的2倍,TA1535溶剂对照的3倍(P>0.05);2.4、1.2、0.6 g/(kg•BW)的赶黄草总黄酮灌胃小鼠,与阴性对照相比,哺乳动物红细胞微核率及小鼠精母细胞染色体畸变率无显著性差异(P>0.05);大鼠在2.4、1.2、0.6 g/(kg•BW)剂量下连续灌胃28 d,受试物各剂量组对大鼠体重、尿常规、血常规指标、血液生化学指标及主要脏器系数与对照组相比均无显著性差异(P>0.05),肝肾组织学检查未发现明显病理变化。赶黄草总黄酮在本试验条件下无急性毒性、遗传毒性、亚急性毒性,赶黄草总黄酮具有较好的安全性。该试验为把赶黄草总黄酮开发为保健食品和功能性食品提供了实验依据。

    Abstract:

    The safety of total flavonoids of Penthorum chinense Pursh (TFPCP) was evaluated. An acute oral toxicity test, three genotoxicity tests, and a 28-day feeding study in rats were conducted to investigate the toxicological safety of TFPCP according to GB 15193-2014 Procedures for Toxicological Assessment of Food and Technical Guidelines for Toxicological Examination and Evaluation of Health Food and its Raw Materials (2020 Edition). These oral acute toxicity studies in mice revealed that the median lethal dose (LD50) of TFPCP was greater than 10 g/(kg•BW), suggesting that TFPCP is non-toxic. In the bacterial reverse mutation (Ames) test, all dose groups produced negative results. Additionally, for all dose groups, the colony counts did not exceed twice those of the solvent controls for TA97A, TA98, and TA100 or three times that for TA1535 (P>0.05). Gavage administration of TFPCP in mice at doses of 2.4, 1.2, and 0.6 g/(kg•BW) revealed no significant differences in mammalian erythrocyte micronucleus and chromosomal aberration test results in mouse spermatocytes compared with the negative control (P>0.05). Three different doses of TFPCP (2.4, 1.2, and 0.6 g/(kg•BW)) were administered to rats by gavage once daily for 28 consecutive days. No significant differences were observed between treated and control groups in terms of body weight, routine urinary and blood parameters, blood biochemical indices, and major organ coefficients (P>0.05). Similarly, histopathological examination of liver and kidney tissues revealed no significant pathological changes. Thus, TFPCP exhibited no acute toxicity, genotoxicity, or subacute toxicity under the conditions examined in this research and demonstrated excellent safety. These findings provide a scientific basis for development of TFPCP as a functional health food.

    参考文献
    相似文献
    引证文献
引用本文

蒋屿,周希,康建英,刘洪盛,李舒婷,袁叶飞,付满玲.赶黄草总黄酮的安全性评价[J].现代食品科技,2025,41(6):298-308.

复制
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2024-04-15
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2025-09-17
  • 出版日期:
文章二维码